Smarter timing of cancer treatments could improve cure rates, study suggests

	Breast Cancer
	The latest breast cancer news from News Medical

	Smarter timing of cancer treatments could improve cure rates, study suggests A new study provides hope that smarter timing of cancer treatments could improve cure rates.

	Preoperative combination treatment shows promise for some patients with pancreatic cancer A new UCLA investigator-initiated study sponsored by the UCLA Health Jonsson Comprehensive Cancer Center has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise for some patients with borderline-resectable pancreatic cancer, a disease that has historically been difficult to treat.

			Researchers discover a way to breach cancer’s impenetrable fortress Researchers at Case Western Reserve University have discovered a way to breach one of cancer's most stubborn defenses: the impenetrable fortress that solid tumors build around themselves.

			Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up suggested durable immune memory with encouraging relapse-free outcomes, though controlled trials are needed to confirm clinical benefit.

			Mayo Clinic collaborates with New Phase Ltd. to install magnetic nanoparticle hyperthermia machine for cancer research Mayo Clinic collaborated with New Phase Ltd. to install the first magnetic nanoparticle-mediated hyperthermia machine for cancer research in the U.S.

	New approach better predicts chemotherapy response in patients with triple-negative breast cancer Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to better account for changes in gene expression within tumors relative to their unique microenvironments.

	Breast screening associated with better ten-year survival in stage IV cancer Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis.

	Low-field MRI could offer an alternative to existing breast cancer screening methods Mass General Brigham's evaluation of low-field MRI performance lays potential groundwork for this technology to be a lower-cost, accessible option for breast imaging.

	An Arm and a Leg: Personal finance guru faces down an insurance denial Less than 36 hours before his wife was scheduled to undergo major surgery, New York Times personal finance columnist Ron Lieber got an unwelcome letter from his family's insurance plan: It was denying prior authorization for the procedure.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026